Editor—Verma and Strauss say that, compared with angiotensin converting enzyme (ACE)
inhibitors, angiotensin receptor blockers do not reduce (and may increase) the risk of …

The Annual Scientific Sessions of the American Heart Association is the leading scientific
conference in the cardiovascular field, both for basic and clinical research in cardiology and …

Angiotensin-converting enzyme inhibitors are proved, effective agents for the treatment of
hypertension and congestive heart failure. New data suggest that angiotensinconverting …

Angiotensin-converting enzyme (ACE) inhibitors are now established drugs in the treatment
of hypertension and heart failure. However, their use in patients after a myocardial infarction …

This is a comment on" Effects of losartan and captopril on mortality and morbidity in high-risk
patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in …

Background Angiotensin-converting–enzyme (ACE) inhibitors such as captopril reduce
mortality and cardiovascular morbidity among patients with myocardial infarction …

Objective To evaluate the effect of angiotensin receptor blockers on the risk of myocardial
infarction in patients at risk for cardiovascular events. Design Systematic review of controlled …

Angiotensin-converting enzyme (ACE) inhibitors have a well-established role in the
management of patients with hypertension, diabetes, heart failure and myocardial infarction …

Which patients with an acute myocardial infarction should be treated with an angiotensin-
converting enzyme (ACE) inhibitor and when should this treatment be initiated? Combining …